These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24183721)

  • 1. Anti-platelet activity of a three-finger toxin (3FTx) from Indian monocled cobra (Naja kaouthia) venom.
    Chanda C; Sarkar A; Sistla S; Chakrabarty D
    Biochem Biophys Res Commun; 2013 Nov; 441(3):550-4. PubMed ID: 24183721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human platelet aggregation by L-amino acid oxidase purified from Naja naja kaouthia venom.
    Sakurai Y; Takatsuka H; Yoshioka A; Matsui T; Suzuki M; Titani K; Fujimura Y
    Toxicon; 2001 Dec; 39(12):1827-33. PubMed ID: 11600144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
    Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
    Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and Characterization of Nk-3FTx: A Three Finger Toxin from the Venom of North East Indian Monocled Cobra.
    Das D; Sharma M; Kumar Das H; Pratim Sahu P; Doley R
    J Biochem Mol Toxicol; 2016 Feb; 30(2):59-70. PubMed ID: 26293154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of a Class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja Naja) venom.
    Satish S; Tejaswini J; Krishnakantha TP; Gowda TV
    Biochimie; 2004 Mar; 86(3):203-10. PubMed ID: 15134835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins.
    Laustsen AH; Gutiérrez JM; Lohse B; Rasmussen AR; Fernández J; Milbo C; Lomonte B
    Toxicon; 2015 Jun; 99():23-35. PubMed ID: 25771242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of catalytic function in the antiplatelet activity of phospholipase A2 cobra (Naja naja naja) venom.
    Rudrammaji LM; Machiah KD; Kantha TP; Gowda TV
    Mol Cell Biochem; 2001 Mar; 219(1-2):39-44. PubMed ID: 11354251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from Indian cobra (Naja naja) venom: inhibition of anticoagulant activity by low molecular weight heparin.
    Dutta S; Gogoi D; Mukherjee AK
    Biochimie; 2015 Mar; 110():93-106. PubMed ID: 25576831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic protein from cobra venom with anti-adhesive properties.
    Chanda C; Sarkar A; Chakrabarty D
    Arch Biochem Biophys; 2016 Jan; 590():20-26. PubMed ID: 26558696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic interference of Indian king cobra (Ophiophagus hannah) Venom. Comparison with three other snake venoms of the subcontinent.
    Gowtham YJ; Kumar MS; Girish KS; Kemparaju K
    Biochemistry (Mosc); 2012 Jun; 77(6):639-47. PubMed ID: 22817464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA; Reimann S; Schrör K
    Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel natriuretic peptide from the cobra venom.
    Zhang Y; Wu J; Yu G; Chen Z; Zhou X; Zhu S; Li R; Zhang Y; Lu Q
    Toxicon; 2011 Jan; 57(1):134-40. PubMed ID: 21050868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxin from Naja naja atra snake venom: a potentiator of platelet aggregation.
    Teng CM; Jy W; Ouyang C
    Toxicon; 1984; 22(3):463-70. PubMed ID: 6474495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
    Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
    J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two acidic, anticoagulant PLA2 isoenzymes purified from the venom of monocled cobra Naja kaouthia exhibit different potency to inhibit thrombin and factor Xa via phospholipids independent, non-enzymatic mechanism.
    Mukherjee AK; Kalita B; Thakur R
    PLoS One; 2014; 9(8):e101334. PubMed ID: 25118676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition.
    Björkman JA; Zachrisson H; Forsberg GB; von Bahr H; Hansson GI; Warner TD; Nylander S
    Thromb Res; 2013 Apr; 131(4):313-9. PubMed ID: 23419412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y12, a new platelet ADP receptor, target of clopidogrel.
    Herbert JM; Savi P
    Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of P2Y(12 ) antagonists as inhibitors of platelet function.
    Iyú D; Glenn JR; White AE; Fox SC; van Giezen H; Nylander S; Heptinstall S
    Thromb Haemost; 2011 Jan; 105(1):96-106. PubMed ID: 20941457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.